Search

Showing 1 - 24 of 66 results

Previous| 1 | 2 | 3 |Next


UCSF Prostate Cancer Specialist Inducted into Annual Class of “Giants of Cancer Care” News

UCSF Prostate Cancer Specialist Inducted into Annual Class of “Giants of Cancer Care”

Eric Small, MD, has been announced as one of the winners of the 10th annual Giants of Cancer Care® awards.
World-Renowned Expert to Lead UCSF’s Hematology and Oncology Division News

World-Renowned Expert to Lead UCSF’s Hematology and Oncology Division

Krishna Komanduri, MD, an international leader in hematology-oncology, transplantation and cellular immunotherapy, is the new chief of UCSF’s Division of Hematology and Oncology.
UCSF Deploys Innovative Data System to Integrate Research and Care News

UCSF Deploys Innovative Data System to Integrate Research and Care

UC San Francisco (UCSF), in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA) has developed the OneSource system to seamlessly integrate clinical care and research data.
Bladder Cancer Home Test Reduced Need for Cystoscopy During COVID-19 News

Bladder Cancer Home Test Reduced Need for Cystoscopy During COVID-19

A study led by UCSF urologic cancer surgeons Sima Porten, MD, MPH, and Maxwell Meng, MD, found that use of a home urine test during the COVID-19 pandemic decreased the frequency of surveillance cystoscopy for patients with a history of non-muscle invasive bladder cancer (NMIBC).
Lung Cancer Screening: Who, How and When to Refer Video

Lung Cancer Screening: Who, How and When to Refer

†horacic radiologist Brett M. Elicker, MD, and thoracic surgeon Johannes Kratz, MD, present about current lung cancer screening guidelines: who, how, and when to refer.
Immune Cells Leave Fingerprints on Tumors Metastasized to the Brain Offering Clues to Future Therapies News

Immune Cells Leave Fingerprints on Tumors Metastasized to the Brain Offering Clues to Future Therapies

Using data from over 100,000 malignant and non-malignant cells from 15 human brain metastases, UCSF researchers have revealed two functional archetypes of metastatic cells across 7 different types of brain tumors, each containing both immune and non-immune cell types. Their findings, published the February 17 issue of CELL, provide a potential roadmap for metastatic tumor formation that could be used to design therapies to improve the treatment of metastasized patients.
Sorting Cancers by “Immune Archetypes” Represents Potential New Approach to Developing Precision Immunotherapies News

Sorting Cancers by “Immune Archetypes” Represents Potential New Approach to Developing Precision Immunotherapies

Using data from over 300 patient tumors, UCSF researchers have described 12 classes of “immune archetypes” to classify cancer tumors. Their findings, published today in CELL, reveal that cancers from different parts of the body are immunologically similar to one another. These classifications provide unique strategies for enhancing each patient’s choice of cancer immunotherapies.
UCSF Study Finds 25% of Patients with HPV+ Oropharynx Cancer May Require Chemoradiotherapy After Robotic Surgery News

UCSF Study Finds 25% of Patients with HPV+ Oropharynx Cancer May Require Chemoradiotherapy After Robotic Surgery

In a nearly 10-year retrospective study involving 136 carefully selected patients with HPV-positive (HPV+) oropharynx cancer, UC San Francisco researchers found that one in four may meet possible indications for adjuvant chemoradiotherapy following transoral robotic surgery (TORS).
UCSF Osher Center Overview: Integrative Medicine’s Value for Providers and Patients Video

UCSF Osher Center Overview: Integrative Medicine’s Value for Providers and Patients

Sanford C. Newmark, MD, medical director of the UCSF Osher Center for Integrative Medicine, explains what integrative medicine is (hint: it’s neither “alternative medicine” nor homeopathy) and how referred patients can benefit from its proven techniques.
International Hematologic Conference Features UCSF Health Experts News

International Hematologic Conference Features UCSF Health Experts

Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 63rd Annual Meeting and Exposition. This year’s meeting will be held in Atlanta, Georgia – and virtually – from December 11-14, 2021.
International Breast Cancer Conference Features UCSF Health Experts News

International Breast Cancer Conference Features UCSF Health Experts

Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 7-10.
Screening for Cervical Cancer: New Evidence on Options and Outcomes Video

Screening for Cervical Cancer: New Evidence on Options and Outcomes

Gynecologic oncologist Megan Swanson, MD, MPH, deciphers recent changes to cervical cancer screening guidelines and uses the data to illuminate the relative value of test options – Pap smears, detection of high-risk HPV strains, or both tests together.
UCSF-Led Study Confirms Some Cancer Immunotherapies May Lead to Myocarditis and Other Potentially Serious Arrhythmias News

UCSF-Led Study Confirms Some Cancer Immunotherapies May Lead to Myocarditis and Other Potentially Serious Arrhythmias

Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis.
Get Current on COVID: The Evidence on Vaccine Efficacy and Strategies for Immunocompromised Patients Video

Get Current on COVID: The Evidence on Vaccine Efficacy and Strategies for Immunocompromised Patients

A panel of experts answers all the current questions on breakthrough infections, who needs boosters, whether to keep recommending masks, and the future of variants, with a spotlight on meeting the needs of the immunocompromised, such as organ transplant recipients and cancer patients. Bonus: what to know about molnupiravir to treat COVID-19.
UCSF’s Lawrence Fong, MD, Earns NCI Award for Cancer Immunotherapy Research News

UCSF’s Lawrence Fong, MD, Earns NCI Award for Cancer Immunotherapy Research

The National Cancer Institute (NCI)has honored Lawrence H. Fong, MD, leader of the UC San Francisco Cancer Immunotherapy Program, with an Outstanding Investigator Award (R35).These awards support investigators who have significant records of productivity in cancer research with multiyear funding for projects of exceptional potential.
An Extraordinary Response: A Young Woman’s Path to Overcoming Metastatic Colon Cancer News

An Extraordinary Response: A Young Woman’s Path to Overcoming Metastatic Colon Cancer

28-year-old woman mother of two was healthy up until a month prior, when she developed severe anemia, diarrhea and emesis, accompanied by a 25-pound weight loss.
UCSF500 Cancer Gene Panel Test Document

UCSF500 Cancer Gene Panel Test

The UCSF500 Cancer Gene Panel is a molecular diagnostic test appropriate for patients with advanced cancer, especially those who experience a poor response to standard therapy.
Proven, Practical Prevention: Lower Your Patients’ Cancer Risks – and Anxiety Video

Proven, Practical Prevention: Lower Your Patients’ Cancer Risks – and Anxiety

In this second part of her series on lifestyle and cancer, medical oncologist Natalie Marshall, MD, offers evidence-based answers to common questions on diet, sleep, and other risk-related factors.
UCSF at the Forefront of New Therapies, Giving Hope to Multiple Myeloma Patients News

UCSF at the Forefront of New Therapies, Giving Hope to Multiple Myeloma Patients

Over the past few decades, advances in the treatment of multiple myeloma (MM) have accelerated at a thrilling pace, with a wealth of new therapeutic options now available for patients with this serious disease.
Advances in Treating Colorectal Cancer With Liver Metastases News

Advances in Treating Colorectal Cancer With Liver Metastases

Giving new hope to potentially thousands of patients, surgeons at UC San Francisco are now providing lifesaving procedures for many colorectal cancer patients whose cancer has spread to the liver.
UCSF Clinic Fills Unmet Need for Managing Oral Side Effects of Cancer Therapies News

UCSF Clinic Fills Unmet Need for Managing Oral Side Effects of Cancer Therapies

As advances in cancer treatments have expanded, so has the number of side effects that impact the mouth. Oral medicine specialists at UC San Francisco are working to mitigate these often-debilitating problems, which affect the majority of patients undergoing or recovering from cancer therapy.
UCSF Oral Oncology Document

UCSF Oral Oncology

The UCSF Oral Oncology Clinic offers consultations for the diagnosis, treatment and management of oral complications from cancer treatment. The clinic is the first and only one of its kind in Northern California.
How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer Outcomes Video

How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer Outcomes

Three surgical oncologists offer exciting news on hepatobiliary, thyroid and breast cancers. First up is a look at benefits of minimally invasive robotic surgery for rectal cancers; regional therapy for metastatic GI cancer; 3D virtual surgical planning; and biomarkers for pancreatic cysts.
CBC: Optimizing Use of an Everyday Blood Test Video

CBC: Optimizing Use of an Everyday Blood Test

Hematologist Neil Dunavin, MD, a specialist in blood cancers and BMT, elucidates the commonly ordered yet imperfectly understood complete blood count, with guidance on which differential type to order and which results call for investigation.

Showing 1 - 24 of 66 results

Previous| 1 | 2 | 3 |Next